CompletedNot Applicable

Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study

France30 participantsStarted 2022-07-12

Plain-language summary

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Who can participate

Age range

25 Years – 55 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria SUBJECTS - Sexual offenders against children: * Right-handed ; * Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ; * Without any Axis 1 disorder ; * Having given informed consent ; * Affiliated to French social health care Exclusion Criteria: * Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders); * Poor understanding of tests and scales instructions ; * Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ; * Gardianship or other tutelage measure Healthy controls : Inclusion Criteria: * Right-handed ; * Without criminal background ; * Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ; * Non-caregiver employee of Le Vinatier Hospital Center. Exclusion Criteria: * Intellectual disability (using fNART if clinical suspicion during run-in period); * Poor understanding of tests and scales instructions ; * Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ; * Gardianship or other tutelage measure.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Amplitude of LPP during the facial emotion stimuli presentation task

Timeframe: one day

Trial details

NCT IDNCT05383235

SponsorHôpital le Vinatier

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-15

View on ClinicalTrials.gov More Child Sexual Abuse trials